Skip to main content
Log in

LncRNA-TUG1 Downregulation is Correlated with the Development of Progressive Chronic Kidney Disease Among Patients with Congestive Heart Failure

  • Original Paper
  • Published:
Molecular Biotechnology Aims and scope Submit manuscript

Abstract

TUG1 is an lncRNA that plays a critical role in kidney injury. Our preliminary sequencing analysis showed altered TUG1 expression in both congestive heart failure (CHF) patients and CHF patients complicated with chronic kidney disease (CKD). We then studied the role of TUG1 in these two diseases. We enrolled 120 CHF patients without obvious complications, 60 CHF patients complicated with CKD, and 60 healthy volunteers. TUG1 expression in plasma samples from these participants was determined using RT-qPCR. The diagnostic value of TUG1 for CKD development in CHF patients was evaluated by ROC curve analysis. A 2-year follow-up was performed to detect the correlation between TUG1 expression levels and the development of CKD in CHF. TUG1 was lowly expressed in CHF patients and was further downregulated in CHF patients complicated with progressive CKD. ROC curve analysis showed that plasma TUG1 expression levels could be used to distinguish CHF patients complicated with CKD from CHF patients without CKD and healthy controls. During the 2-year follow-up, high CHF expression levels predicted a low incidence of progressive CKD among CHF patients. With the treatment of progressive CHF + CKD, plasma TUG1 was upregulated. LncRNA-TUG1 downregulation may develop the progressive CKD among patients with CHF.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Stein, P., & Pu, Y. (2012). Heart rate variability in congestive heart failure. In: Heart Rate Variability (HRV) signal analysis (pp. 303–324). CRC Press.

  2. Javaheri, A., Shewale, S., Frej, C., Liu, M., Bedi, K., Brandimarto, J., Mu, A., Wang, T., Chen, C. Y., & Ma, X. (2016). Apolipoprotein M improves survival in congestive heart failure via enhanced Akt signaling. Journal of Cardiac Failure, 22(8), S1.

    Article  Google Scholar 

  3. Tran, H. A., Lin, F., & Greenberg, B. H. (2016). Potential new drug treatments for congestive heart failure. Expert Opinion on Investigational Drugs, 25(7), 811–826.

    Article  CAS  Google Scholar 

  4. Damman, K., & Testani, J. M. (2015). The kidney in heart failure: An update. European Heart Journal, 36(23), 1437–1444.

    Article  Google Scholar 

  5. Jungbauer, C. G., Birner, C., Jung, B., Buchner, S., Lubnow, M., von Bary, C., Endemann, D., Banas, B., Mack, M., Boger, C. A., Riegger, G., & Luchner, A. (2011). Kidney injury molecule-1 and N-acetyl-beta-D-glucosaminidase in chronic heart failure: Possible biomarkers of cardiorenal syndrome. European Journal of Heart Failure, 13(10), 1104–1110.

    Article  CAS  Google Scholar 

  6. Kovesdy, C. P., Lott, E. H., Lu, J. L., Malakauskas, S. M., Ma, J. Z., Molnar, M. Z., & Kalantar-Zadeh, K. (2012). Hyponatremia, hypernatremia, and mortality in patients with chronic kidney disease with and without congestive heart failure. Circulation, 125(5), 677–684.

    Article  Google Scholar 

  7. Popolo, A., Autore, G., Pinto, A., & Marzocco, S. (2013). Oxidative stress in patients with cardiovascular disease and chronic renal failure. Free Radical Research, 47(5), 346–356.

    Article  CAS  Google Scholar 

  8. Quinn, J. J., & Chang, H. Y. (2016). Unique features of long non-coding RNA biogenesis and function. Nature Reviews Genetics, 17(1), 47–62.

    Article  CAS  Google Scholar 

  9. Engreitz, J. M., Ollikainen, N., & Guttman, M. (2016). Long non-coding RNAs: Spatial amplifiers that control nuclear structure and gene expression. Nature Reviews Molecular Cell Biology, 17(12), 756–770.

    Article  CAS  Google Scholar 

  10. Lorenzen, J. M., & Thum, T. (2016). Long noncoding RNAs in kidney and cardiovascular diseases. Nature Reviews. Nephrology, 12(6), 360–373.

    Article  CAS  Google Scholar 

  11. Santer, L., Lopez, B., Ravassa, S., Baer, C., Riedel, I., Chatterjee, S., Moreno, M. U., Gonzalez, A., Querejeta, R., Pinet, F., Thum, T., & Diez, J. (2019). Circulating long noncoding RNA LIPCAR predicts heart failure outcomes in patients without chronic kidney disease. Hypertension, 73(4), 820–828.

    Article  CAS  Google Scholar 

  12. Zhou, H., Wang, B., Yang, Y. X., Jia, Q. J., Zhang, A., Qi, Z. W., & Zhang, J. P. (2019). Long noncoding RNAs in pathological cardiac remodeling: A review of the update literature. BioMed Research International, 2019, 7159592.

    PubMed  PubMed Central  Google Scholar 

  13. Hobuß, L., Bär, C., & Thum, T. (2019). Long non-coding RNAs: At the heart of cardiac dysfunction? Frontiers in Physiology. https://doi.org/10.3389/fphys.2019.00030

    Article  PubMed  PubMed Central  Google Scholar 

  14. Moreno, J. A., Hamza, E., Guerrero-Hue, M., Rayego-Mateos, S., García-Caballero, Vallejo-Mudarra, M., Metzinger, L., & Metzinger-Le Meuth, V. (2021). Non-coding RNAs in kidney diseases: The long and short of them. International Journal of Molecular Sciences, 22(11), 6077.

    Article  CAS  Google Scholar 

  15. Liu, X., Hong, C., Wu, S., Song, S., Yang, Z., Cao, L., Song, T., & Yang, Y. (2019). Downregulation of lncRNA TUG1 contributes to the development of sepsis-associated acute kidney injury via regulating miR-142-3p/sirtuin 1 axis and modulating NF-kappaB pathway. Journal of Cellular Biochemistry.

  16. Li, J., Zhang, M., An, G., & Ma, Q. (2016). LncRNA TUG1 acts as a tumor suppressor in human glioma by promoting cell apoptosis. Experimental Biology and Medicine (Maywood, NJ), 241(6), 644–649.

    Article  CAS  Google Scholar 

  17. Yun-Bo, F., Xiao-Po, L., Xiao-Li, L., Guo-Long, C., Pei, Z., & Fa-Ming, T. (2016). LncRNA TUG1 is upregulated and promotes cell proliferation in osteosarcoma. Open Med (Wars), 11(1), 163–167.

    Article  Google Scholar 

  18. Chen, S., Wang, M., Yang, H., Mao, L., He, Q., Jin, H., Ye, Z. M., Luo, X. Y., Xia, Y. P., & Hu, B. (2017). LncRNA TUG1 sponges microRNA-9 to promote neurons apoptosis by up-regulated Bcl2l11 under ischemia. Biochemical and Biophysical Research Communications, 485(1), 167–173.

    Article  Google Scholar 

  19. Xu, Y., Ge, Z., Zhang, E., Zuo, Q., Huang, S., Yang, N., Wu, D., Zhang, Y., Chen, Y., Xu, H., Huang, H., Jiang, Z., & Sun, L. (2017). The lncRNA TUG1 modulates proliferation in trophoblast cells via epigenetic suppression of RND3. Cell Death & Disease, 8(10), e3104.

    Article  CAS  Google Scholar 

  20. Schefold, J. C., Filippatos, G., Hasenfuss, G., Anker, S. D., & von Haehling, S. (2016). Heart failure and kidney dysfunction: Epidemiology, mechanisms and management. Nature Reviews Nephrology, 12(10), 610–623.

    Article  CAS  Google Scholar 

  21. Unger, E. D., Dubin, R. F., Deo, R., Daruwalla, V., Friedman, J. L., Medina, C., Beussink, L., Freed, B. H., & Shah, S. J. (2016). Association of chronic kidney disease with abnormal cardiac mechanics and adverse outcomes in patients with heart failure and preserved ejection fraction. European Journal of Heart Failure, 18(1), 103–112.

    Article  Google Scholar 

  22. Zhang, W., Zhou, X., Zhang, H., Yao, Q., Liu, Y., & Dong, Z. (2016). Extracellular vesicles in diagnosis and therapy of kidney diseases. American Journal of Physiology. Renal Physiology, 311(5), F844–F851.

    Article  CAS  Google Scholar 

  23. Metzinger-Le Meuth, V., Fourdinier, O., Charnaux, N., Massy, Z., & Metzinger, L. (2019). The expanding roles of microRNAs in kidney pathophysiology. Nephrology Dialysis Transplantation, 34(1), 7–15.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Xuezheng Liu.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhao, W., Zhang, Y., Zhang, M. et al. LncRNA-TUG1 Downregulation is Correlated with the Development of Progressive Chronic Kidney Disease Among Patients with Congestive Heart Failure. Mol Biotechnol 64, 493–498 (2022). https://doi.org/10.1007/s12033-021-00427-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12033-021-00427-3

Keywords

Navigation